{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:39:24Z","timestamp":1762508364728,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ygyno.2021.01.003","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T15:58:12Z","timestamp":1611417492000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Optimal overall treatment time for adjuvant therapy for women with completely resected, node-positive vulvar cancer"],"prefix":"10.1016","volume":"161","author":[{"given":"Sarah","family":"Ashmore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Crafton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirwen M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Krivak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomiya R.","family":"Teterichko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paniti","family":"Sukumvanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akila N.","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary D.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.01.003_bb0005","unstructured":"Vulvar Cancer \u2014 Cancer Stat Facts. https:\/\/seer.cancer.gov\/statfacts\/html\/vulva.html. Accessed April 26, 2020."},{"year":"2020","series-title":"NCCN Guidelines Version 1.2020 Vulvar Cancer (Squamous Cell Carcinoma)","author":"Gaffney","key":"10.1016\/j.ygyno.2021.01.003_bb0010"},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.003_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0090-8258(90)90064-R","article-title":"Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva","volume":"38","author":"Heaps","year":"1990","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.003_bb0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ygyno.2017.11.006","article-title":"Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: a systematic review","volume":"148","author":"te Grootenhuis","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2021.01.003_bb0025","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.ejso.2019.07.029","article-title":"Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: the role of perineural invasion in recurrence and survival","volume":"45","author":"Ferrari","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.003_bb0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0b013e3181b12f99","article-title":"Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial","volume":"114","author":"Kunos","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.003_bb0035","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ygyno.2006.06.030","article-title":"The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma","volume":"103","author":"Parthasarathy","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.01.003_bb0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ygyno.2009.05.017","article-title":"Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial","volume":"114","author":"Fons","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.003_bb0045","series-title":"Gynecologic Oncology","first-page":"365","article-title":"Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis","volume":"137","author":"Gill","year":"2015"},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.003_bb0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.radonc.2018.03.023","article-title":"Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: a National Cancer Database study","volume":"129","author":"Rydzewski","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.01.003_bb0055","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2007.14.0566","article-title":"Sentinel node dissection is safe in the treatment of early-stage vulvar cancer","volume":"26","author":"Van Der Zee","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2021.01.003_bb0060","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1002\/hed.25914","article-title":"The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation","volume":"41","author":"Chao","year":"2019","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.003_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0360-3016(01)01690-X","article-title":"Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer","volume":"51","author":"Ang","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.003_bb0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2021.01.003_bb0075","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/IGC.0000000000001307","article-title":"The selection of time interval between surgery and adjuvant therapy in early stage cervical Cancer","volume":"28","author":"You","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.003_bb0080","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e42","article-title":"Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer","volume":"28","author":"Hanprasertpong","year":"2017","journal-title":"J. Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.01.003_bb0085","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ijrobp.2017.03.045","article-title":"Adjuvant Chemoradiation therapy for cervical Cancer and effect of timing and duration on treatment outcome","volume":"98","author":"Jhawar","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9538","key":"10.1016\/j.ygyno.2021.01.003_bb0090","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.003_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2015.09.077","article-title":"Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational study on sentinel nodes in vulvar cancer (GROINSS-V) i","volume":"140","author":"Te Grootenhuis","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.003_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.07.007","article-title":"Risk factors and treatment for recurrent vulvar squamous cell carcinoma","volume":"106","author":"Nooij","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.003_bb0105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/IGC.0000000000000637","article-title":"Should groin recurrence still be considered as a palliative situation in vulvar Cancer patients?: a brief report","volume":"26","author":"Frey","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.003_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2017.05.004","article-title":"Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer","volume":"146","author":"Swanick","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.01.003_bb0115","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/bjc.2011.407","article-title":"Risk factors for short-and long-term complications after groin surgery in vulvar cancer","volume":"105","author":"Hinten","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.003_bb0120","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ijgc-00009577-200307000-00019","article-title":"Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions","volume":"13","author":"Gaarenstroom","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.01.003_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00118","article-title":"Radiation Records in the National Cancer Database: variations in coding and\/or practice can significantly Alter survival results","volume":"3","author":"Jacobs","year":"2019","journal-title":"JCO Clin Cancer Informatics."},{"issue":"2","key":"10.1016\/j.ygyno.2021.01.003_bb0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(11)70346-1","article-title":"Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial","volume":"13","author":"Bourhis","year":"2012","journal-title":"Lancet Oncol."},{"issue":"15_suppl","key":"10.1016\/j.ygyno.2021.01.003_bb0135","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1200\/jco.2010.28.15_suppl.5507","article-title":"A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): Impact of radiation and cisplatin intensity on outcome","volume":"28","author":"Ang","year":"2010","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:58:43Z","timestamp":1758772723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0090825821000032"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.01.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal overall treatment time for adjuvant therapy for women with completely resected, node-positive vulvar cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}